NCT05995379View on ClinicalTrials.gov

Donor Derived Cell-free DNA and Rejection of Kidney Allografts

CompletedOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

September 21, 2011

Primary Completion Date

August 9, 2022

Study Completion Date

August 9, 2022

Conditions
Kidney Rejection Transplant
Interventions
DIAGNOSTIC_TEST

Donor-derived cell-free DNA

"Cell-free DNA (cfDNA) is fragmented extracellular DNA released in the bloodstream from cells undergoing apoptosis or necrosis. In transplantation, donor-derived cfDNA (dd-cfDNA) is detected in the blood of kidney recipients and has been proposed as a noninvasive biomarker to detect rejection.~One additional blood sample will be collected and dd-cfDNA levels will be centrally analyzed."

All Listed Sponsors
lead

Paris Translational Research Center for Organ Transplantation

OTHER

NCT05995379 - Donor Derived Cell-free DNA and Rejection of Kidney Allografts | Biotech Hunter | Biotech Hunter